The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aegerion Pharmaceuticals, Inc. | NOTE | 00767EAB8 | 13,280 | 16,600,000 | PRN | SOLE | 0 | 0 | 0 | ||
| Alimera Sciences, Inc | COM | 016259103 | 3,607 | 2,576,273 | SH | SOLE | 2,576,273 | 0 | 0 | ||
| Alere Inc. | COM | 01449J105 | 10,926 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| Avadel Pharmaceuticals PLC | SPONS ADR | 05337M104 | 7,283 | 752,410 | SH | SOLE | 752,410 | 0 | 0 | ||
| Aviragen Therapeutics, Inc. | COM | 053761102 | 205 | 314,421 | SH | SOLE | 314,421 | 0 | 0 | ||
| Biodelivery Sciences INTL | COM | 09060J106 | 5,405 | 2,844,820 | SH | SOLE | 2,844,820 | 0 | 0 | ||
| Cumberland Pharmaceuticals, Inc. | COM | 230770109 | 5,135 | 739,917 | SH | SOLE | 739,917 | 0 | 0 | ||
| Cardiome Pharma Corp | COM | 14159U301 | 8,299 | 2,757,260 | SH | SOLE | 2,757,260 | 0 | 0 | ||
| Durect Corporation | COM | 266605104 | 2,941 | 2,801,376 | SH | SOLE | 2,801,376 | 0 | 0 | ||
| Emergent Biosolutions Inc | COM | 29089Q105 | 1,583 | 54,505 | SH | SOLE | 54,505 | 0 | 0 | ||
| Enanta Pharmaceuticals | COM | 29251M106 | 5,701 | 185,099 | SH | SOLE | 185,099 | 0 | 0 | ||
| Novelion Therapeutics, Inc. | COM | 67001K202 | 16,760 | 1,560,487 | SH | SOLE | 1,560,487 | 0 | 0 | ||
| Ophthotech Corp | COM | 683745103 | 12,870 | 3,516,489 | SH | SOLE | 3,516,489 | 0 | 0 | ||
| Recro Pharma, Inc. | COM | 75629F109 | 25,122 | 2,874,317 | SH | SOLE | 2,874,317 | 0 | 0 | ||
| Sciclone Pharmaceuticals, Inc. | COM | 80862K104 | 16,300 | 1,663,281 | SH | SOLE | 1,663,281 | 0 | 0 | ||
| Trinity Biotech PLC - SPON ADR | SPONS ADR | 896438306 | 2,097 | 351,917 | SH | SOLE | 351,917 | 0 | 0 | ||
| Vericel Corp | COM | 92346J108 | 9,143 | 3,265,323 | SH | SOLE | 3,265,323 | 0 | 0 | ||
| Veracyte, Inc. | COM | 92337F107 | 5,308 | 578,200 | SH | SOLE | 578,200 | 0 | 0 | ||
| Viveve Medical, Inc | COM | 92852W204 | 24,256 | 3,849,711 | SH | SOLE | 3,849,711 | 0 | 0 | ||
| VANDA PHARMACEUTICALS INC | COM | 921659108 | 606 | 43,300 | SH | SOLE | 43,300 | 0 | 0 | ||
| XOMA CORP | COM | 98419J206 | 625 | 87,960 | SH | SOLE | 87,960 | 0 | 0 | ||